{"id":"W3193427671","doi":"10.1212/nxi.0000000000001057","title":"COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America","year":2021,"lang":"en","type":"article","venue":"Neurology Neuroimmunology & Neuroinflammation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Multiple Sclerosis Society of Canada; University of British Columbia","funders":"Janssen Pharmaceuticals; Teva Pharmaceutical Industries; National Center for Advancing Translational Sciences; National Cancer Institute; Sanofi Genzyme; Greenwich Biosciences; EMD Serono; Genentech; National Heart, Lung, and Blood Institute; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; BioDelivery Sciences International; MedDay Pharmaceuticals; Horizon Pharmaceuticals; Sanofi; GW Pharmaceuticals; Bristol-Myers Squibb; CSL Behring; AveXis; Pfizer; Biogen; Celgene; U.S. Department of Defense; TG Therapeutics","keywords":"Medicine; Neuromyelitis optica; Internal medicine; Multiple sclerosis; Comorbidity; Rituximab; Pediatrics; Immunology; Lymphoma","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001203273,0.0004957467,0.0007977453,0.0007599473,0.0002005534,0.00003928426,0.0002275839,0.0001601913,0.00008753479],"category_scores_gemma":[0.003123601,0.0004813658,0.00008920418,0.001161264,0.0008157364,0.0002742785,0.0004101898,0.001312604,0.00003231376],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001014937,"about_ca_system_score_gemma":0.0005524814,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002367131,"about_ca_topic_score_gemma":0.002161388,"domain_scores_codex":[0.9954815,0.0009864417,0.0007527776,0.001350215,0.0004698368,0.0009592494],"domain_scores_gemma":[0.9978126,0.0005437735,0.0002296564,0.0008470461,0.00009918925,0.00046769],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006454216,0.000518569,0.9793965,0.0001661021,0.00003984039,0.002866987,0.0002425623,0.001328201,0.004253746,0.00005819707,0.0000143921,0.004660649],"study_design_scores_gemma":[0.008187733,0.001748823,0.9853511,0.00002643116,0.00004147098,0.00008797299,0.00001593747,0.001698911,0.0001100202,0.00006223573,0.002382251,0.0002870903],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9645329,0.0002052697,0.00003659686,0.03322059,0.0001585094,0.001564447,0.00004171311,0.0001363517,0.0001036516],"genre_scores_gemma":[0.9932541,0.002997246,0.00007175683,0.003021649,0.00004525217,0.0001401173,0.0003622544,0.00007743083,0.00003018519],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03019893,"threshold_uncertainty_score":0.9997638,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009756802565880364,"score_gpt":0.2588710660790786,"score_spread":0.2491142635131983,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}